Wingspan M003WS0300090Recalls & reported problems
Stryker Corporation · Stent System · Class f · Implant
All models of Wingspan (12)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04546540722799), received between Jul 1, 2016 and May 4, 2022 — classified as 1 death, 2 malfunctions.
The most frequently reported specific device problem is “Fracture” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Fracture1
- Premature Activation1
- Premature Separation1
Patient problems
- Death1
- Intracranial Hemorrhage1
- No Clinical Signs, Symptoms or Conditions1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 4, 2022Fracture; Premature Activation; Fracture; Premature Activation
IT WAS REPORTED THAT DURING PROCEDURE AT M1 TREATMENT SITE, DURING DEPLOYMENT OF THE STENT (SUBJECT DEVICE), THE CUSTOMER FELT FRICTION WHILE TRYING TO PUSH THE HYPO TUBE INTO THE OUTER BODY OF THE DEVICE (RESISTANCE FELT WHEN TRYING TO DEPLOY THE STENT BY PULLING BACK THE OUTER BODY). AT ONE POINT, THE HUB OF THE OUTER BODY BROKE OFF THE CATHETER AND THE CATHETER APPEARED TO BE STRETCHED IN ONE SEGMENT OF THE CATHETER. THE CUSTOMER OPTED TO PULL THE DEVICE OUT BUT THAT INADVERTENTLY DEPLOYED THE STENT (SUBJECT DEVICE). HOWEVER, THE STENT (SUBJECT DEVICE) WAS DEPLOYED AT THE CORRECT POSITION THAT HE WANTED THE STENT TO DEPLOY. HE THEN CAREFULLY PULLED THE SYSTEM OUT. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH THE SAME DEVICE. AFTER PULLING THE SYSTEM OUT, WE NOTICED THE HUB OF THE OUTER BODY HAD BROKEN OFF AND NOTICED THE STRETCHING OF THE MICROCATHETER. THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO CLINICAL CONSEQUENCES WERE REPORTED DUE TO THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14274949 ↗MalfunctionDec 12, 2018Premature Separation; Premature Separation
IT WAS REPORTED THAT THE PHYSICIAN EXPERIENCED RESISTANCE DURING STENT (SUBJECT DEVICE) DEPLOYMENT DURING THE PROCEDURE AND UPON REMOVAL, THE STENT DETACHED PREMATURELY INSIDE THE GUIDE CATHETER. THERE WERE NO REPORTED CLINICAL CONSEQUENCES TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8158539 ↗DeathJul 1, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT FOLLOWING ANGIOPLASTY AND STENTING PROCEDURE FOR LEFT MIDDLE CEREBRAL ARTERY (MCA) STENOSIS, THE PATIENT'S CONDITION WAS STABLE AND AT NEUROLOGICAL BASELINE. APPROXIMATELY 18 HOURS POST PROCEDURE, HEMORRHAGE OCCURRED IN THE LEFT MCA TERRITORY. DECOMPRESSIVE CRANIECTOMY WAS ATTEMPTED BY THE PHYSICIAN TO TRY TO RESOLVE THE EVENT. THE EVENT WAS NOT RESOLVED AND EVALUATED BY PHYSICIAN TO BE A SERIOUS INJURY. PATIENT'S CONDITION WORSENED AND PATIENT EXPIRED 8 DAYS AFTER PROCEDURE. THE PHYSICIAN CONSIDERED THE ADVERSE EVENT AND SUBSEQUENT DEATH UNRELATED TO THE DEVICE. OTHER POSSIBLE CONTRIBUTING FACTORS TO THE EVENT WERE HYPERTENSION.
Patient problems: Death; Intracranial Hemorrhage
MAUDE report 5765194 ↗
Other intracranial neurovascular stent devices
- CERENOVUS ENTERPRISE ENF402312Medos International Sàrl · intracranial neurovascular stent1 death90 reports
- PulseRider Aneurysm Neck Reconstruction Device 201-DMedos International Sàrl · Intracranial Neurovascular Stent2 deaths74 reports
- CERENOVUS ENTERPRISE ENF402300Medos International Sàrl · intracranial neurovascular stent2 deaths66 reports
- CERENOVUS ENTERPRISE ENF403012Medos International Sàrl · intracranial neurovascular stent1 death42 reports
- CERENOVUS ENTERPRISE ENF452212Medos International Sàrl · intracranial neurovascular stent41 reports
- CERENOVUS ENTERPRISE ENF401600Medos International Sàrl · intracranial neurovascular stent36 reports
- CERENOVUS ENTERPRISE ENF401612Medos International Sàrl · intracranial neurovascular stent36 reports
- CERENOVUS ENTERPRISE ENF452812Medos International Sàrl · intracranial neurovascular stent31 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page